Profound Medical Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Profound Medical Corp inventory turnover ratio, the Profound Medical Corp 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1 in the first quarter 2026, a new company high. Average inventory processing period, for the Profound Medical in Mar 31 2026 quarter, has decreased to 365 days, compare to 415 days, in the Dec 31 2025 quarter.

Within Healthcare sector 311 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1495 in the fourth quarter 2025, to 1583.

PROF Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Profound Medical Corp Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PROF Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	10.36 %	37.61 %	25.98 %	-	-
Y / Y Cost of Sales Growth	95.96 %	63.59 %	30.08 %	-26.97 %	34.03 %
Inventory Turnover Ratio (TTM)	1	0.88	0.79	0.77	1.17
PROF's Total Ranking	# 1583	# 1495	# 1163	# 0	# 0
Average inventory processing period	366	415	462	472	312
Seq. Inventory Growth	-3.2 %	-9.64 %	3.95 %	21.38 %	20.69 %
Seq. Cost of Sales Growth	-24.22 %	46.24 %	129.01 %	-22.79 %	-36.74 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 141
Healthcare Sector	# 312
Overall Market	# 1583

Inventory Turnover Ratio Statistics
High	Average	Low
1	0.86	0.77
(Mar 31 2026)		(Jun 30 2025)

PROF Company Profile >> Back to PROF Efficiency Comparisons >> Compare PROF Inventory Turnover Ratio to its Competitors

Financial Statements
Profound Medical 's Inventories	$ 5 Millions	Visit PROF's Balance sheet
Profound Medical 's Cost of Revenues TTM	$ 5 Millions	Visit PROF's Income Statement
What are PROF's Sales?		Visit PROF's Sales by Segment

Other Inventory Turnover Ratios
Profound Medical 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PROF's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PROF's Competitors
Inventory Turnover Ratio for PROF's Suppliers
Inventory Turnover Ratio for PROF's Customers

You may also want to know
PROF's Sales Growth Rates	PROF's Pe Price to earnings ratio	PROF's Receivables Turnover Ratio	PROF's Stock Quote
PROF's Net Income Growth Rates	PROF's Ps Price to Sales ratio	PROF's Sales per Employee	PROF's Asset Turnover Ratio
PROF's Net Margin	PROF's Pb Price to Book ratio	PROF's Financial Strength Ratios	PROF's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Msa Safety Inc	2.93	$ 1,020.000 Millions	$ 349 Millions
Nexgel Inc	2.92	$ 6.000 Millions	$ 2 Millions
Abbott Laboratories	2.91	$ 19,741.000 Millions	$ 6,785 Millions
Zai Lab Limited	2.91	$ 128.112 Millions	$ 44 Millions
Mimedx Group Inc	2.87	$ 74.000 Millions	$ 26 Millions
Dentsply Sirona Inc	2.82	$ 1,880.000 Millions	$ 666 Millions
Catalyst Pharmaceuticals Inc	2.82	$ 83.817 Millions	$ 30 Millions
Evofem Biosciences Inc	2.82	$ 4.662 Millions	$ 2 Millions
Livanova Plc	2.80	$ 464.684 Millions	$ 166 Millions
Orthofix Medical Inc	2.79	$ 242.580 Millions	$ 87 Millions
Lifecore Biomedical Inc	2.76	$ 89.000 Millions	$ 32 Millions
Zeo Scientifix Inc	2.76	$ 1.291 Millions	$ 0 Millions
Akebia Therapeutics Inc	2.76	$ 44.127 Millions	$ 16 Millions
Biomerica Inc	2.72	$ 4.142 Millions	$ 2 Millions
Nephros Inc	2.71	$ 8.000 Millions	$ 3 Millions
Neogen Corporation	2.70	$ 478.000 Millions	$ 177 Millions
Merck and Co Inc	2.62	$ 17,158.000 Millions	$ 6,546 Millions
Ligand Pharmaceuticals Incorporated	2.62	$ 32.548 Millions	$ 12 Millions
Electrocore Inc	2.57	$ 4.012 Millions	$ 2 Millions
Anika Therapeutics Inc	2.57	$ 48.000 Millions	$ 19 Millions
Illumina Inc	2.54	$ 1,485.000 Millions	$ 585 Millions
Ani Pharmaceuticals Inc	2.53	$ 361.855 Millions	$ 143 Millions
International Stem Cell Corporation	2.49	$ 3.995 Millions	$ 2 Millions
Quidelortho Corp	2.46	$ 1,462.500 Millions	$ 595 Millions
Pro dex Inc	2.45	$ 53.903 Millions	$ 22 Millions
Avanos Medical Inc	2.44	$ 355.900 Millions	$ 146 Millions
Aquestive Therapeutics Inc	2.43	$ 18.372 Millions	$ 8 Millions
United Therapeutics Corporation	2.41	$ 425.300 Millions	$ 177 Millions
Urogen Pharma Ltd	2.38	$ 14.256 Millions	$ 6 Millions
Merit Medical Systems Inc	2.37	$ 791.837 Millions	$ 334 Millions

Date modified: 2026-07-07T13:15:25+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.